Incidence of thyroid cancer has doubled globally, analysis finds

The number of people diagnosed with thyroid cancer has more than doubled worldwide since 1990, fueled by a rise in cases in Asia. The United States accounts for 10 percent of cases worldwide.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news

Related Links:

Publication date: Available online 30 June 2020Source: Molecular and Cellular EndocrinologyAuthor(s): Chang'an Zhao, Liping Mo, Chao Li, Shuiping Han, Wenbo Zhao, Lifeng Liu
Source: Molecular and Cellular Endocrinology - Category: Endocrinology Source Type: research
Authors: Markova ND Abstract The current review provides data and focuses on blood as a niche for the presence of cell wall-deficient microbes (L-forms). The hypothesis for the existence of L-form microbiota in humans was tested by us using an innovative methodology for the isolation of L-form cultures from human blood. Criteria were conceived for the individual assessment of blood microbiota and recognition of two types of states -- "eubiotic" and "dysbiotic" blood microbiota. Cell wall-deficient microbes (CWD) that inhabit blood in healthy people are in natural balance with the host homeostasi...
Source: Discovery Medicine - Category: Research Tags: Discov Med Source Type: research
Researchers from across the U.S. confirmed the efficacy of 3D color-flow ultrasound...Read more on AuntMinnie.comRelated Reading: QT Ultrasound touts presentations on 3D ultrasound Researchers develop mini 3D ultrasound for scoliosis Automated 3D US effective for diagnosing hip dysplasia 4D ultrasound contrast HSG assesses fallopian tubes 3D tumor measurements on US spot thyroid cancer growth
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
TUESDAY, June 30, 2020 -- There is an increasing global burden of thyroid cancer, according to a study published online June 26 in JAMA Network Open. YuJiao Deng, Ph.D., from the First Affiliated Hospital of Zhejiang University Hangzhou, China, and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
ConclusionDepending on nuclear or cytoplasmic expression, our study shows that THR α and its isoforms 1 and 2 provide different prognostic information for ovarian cancer patients. Further investigations should analyze if THRs may represent new endocrine targets for the treatment of ovarian cancer.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
Enhancers are cis-regulatory DNA elements that positively regulate the transcription of target genes in a tissue-specific manner, and dysregulation of target genes could lead to various diseases, such as cancer. Recent studies have shown that enhancers can regulate microRNAs (miRNAs) and participate in their biological synthesis. However, the network of enhancer-regulated miRNAs across multiple cancers is still unclear. Here, a total of 2,418 proximal enhancer–miRNA interactions and 1,280 distal enhancer–miRNA interactions were identified through the integration of genomic distance, co-expression, and 3D genome...
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
Thyroid lobectomy is performed for symptomatic benign nodules, indeterminate nodules, or low-risk well-differentiated thyroid cancer. We aimed to determine factors associated with need for thyroid hormone supplementation following thyroid lobectomy.
Source: American Journal of Surgery - Category: Surgery Authors: Source Type: research
Conclusion68 Ga-DOTATATE is an essential part of the work-up for patients with MTC. This modality outperformed CI in 14/38 (37%) patients and changed the clinical management in 13/38 (34%) patients. Prospective randomized studies with image-guided therapy decisions are needed to further reveal the impact of PE T imaging in patients with MTC.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
Publication date: Available online 27 June 2020Source: European Journal of Surgical OncologyAuthor(s): Ashok R. Shaha, Ronald Ghossein, R. Michael Tuttle
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
In conclusion, IGHBP3 might be involved in the development of LNM in PTC patients. IGHBP3 over-expression might be a novel indicator and a potential target for PTC therapy.
Source: Clinical and Experimental Medicine - Category: Research Source Type: research
More News: Cancer | Cancer & Oncology | Health | Thyroid | Thyroid Cancer | USA Health